Back to BlackRock, Inc. BlackRock, Inc.

ANTXANTX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in AN2 THERAPEUTICS INC

BlackRock, Inc. holds 1.7M shares of ANTX (AN2 THERAPEUTICS INC), worth $8.1M as of 2026-Q2. The position was increased (+422.5% shares). ANTX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$8.1M

Current Shares

1.7M

Total Value Change

+$7.6M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.7M
+422.5%
$8.1M0.0%$4.84
44
2026-Q1
Decreased
318,768
-1.4%
$1.1M0.0%$1.06
0
2025-Q4
Increased
323,335
+0.8%
$368,6020.0%$1.08
16
2025-Q3
Increased
320,911
+0.5%
$407,5570.0%$1.28
16
2025-Q2
Increased
319,295
+6.2%
$338,4530.0%$1.08
17
2025-Q1
Decreased
300,686
-0.2%
$408,9320.0%$1.39
0
2024-Q4
New
301,421
-
$415,9610.0%$1.41
37

Other major holders of ANTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used